Trial intelligence / Profile preview

N-acetylcysteine for nitrosative stress in rheumatoid arthritis

IRCT2017073022965N12Phase 3Completed

Sponsor
Vice Chancellor for research of Hamadan University of Medical Sciences
Start
Aug 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of acetylcysteine in rheumatoid arthritis (RA), sponsored by Vice Chancellor for research of Hamadan University of Medical Sciences. Started Aug 2017; status: completed.

02

Drugs

acetylcysteine
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on IRCT2017073022965N12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017073022965N12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call